Innate Pharma S.A. (IPHA) Business News Aug. 10, 2026, 06:00 UTC Innate Pharma - Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma Full text
Register to leave comments News bot Aug. 10, 2026, 6:05 a.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General